Ramyashree Tummala is a Cardiology physician. OpenAlex indexes 30 publications with 526 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
112 NE Crescent Ave
Peoria, IL 616061901
Telephone
309-672-4670Provider last certified this registry record 21 Oct 2025.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20252 payments
- Abbott LaboratoriesProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.3%Beta blocker27.7%Metoprolol Succinate47%Metoprolol Tartrate31%Carvedilol17%Atenolol5%Bisoprolol Fumarate2%Part D<11 patientsStatin14.8%Atorvastatin Calcium80%Rosuvastatin Calcium14%Simvastatin4%Pravastatin Sodium2%Part D<11 patients+ 13 more classes in this area
Blood & clotting
17.1%Factor Xa inhibitor12.3%Eliquis82%Xarelto18%Part D≥76 patientsP2Y12 inhibitor3.8%Clopidogrel100%Part D≥45 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.7%Potassium supplement2.8%Potassium Chloride66%Klor-Con M2034%Part D≥23 patientsSGLT2 inhibitor0.8%Jardiance100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep Learning for Explainable Estimation of Mortality Risk From Myocardial Positron Emission Tomography Images
Circulation Cardiovascular Imaging
2022 - Association between plaque localization in proximal coronary segments and MACE outcomes in patients with mild CAC: Results from the EISNER study
American Journal of Preventive Cardiology
2022 - PROGNOSTIC VALUE OF CORONARY ARTERY CALCIUM AND MYOCARDIAL FLOW RESERVE FROM 82RB PET MPI IN HEART TRANSPLANT PATIENTS
Journal of the American College of Cardiology
2022 - PROGNOSTIC SIGNIFICANCE OF PROXIMAL INVOLVEMENT CAC IN ASYMPTOMATIC PATIENTS: FROM EISNER TRIAL
Journal of the American College of Cardiology
2022 - IMPACT OF GENDER ON THE ASSOCIATIONS OF EPICARDIAL ADIPOSE TISSUE, CORONARY ARTERY CALCIUM, AND LIVER FIBROSIS IN PREDICTION OF MACE: SUBSTUDY OF THE EISNER TRIAL
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”